SCHEMBL7469707

SCHEMBL7469707

Cc1cc2c(cc1Cl)C(c1ccccc1Cl)C(=O)N2

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 2/20 0.41
MAPT P10636 6/20 0.39
ALDH1A1 P00352 5/20 0.39
MEN1 O00255 3/20 0.39
KMT2A Q03164 3/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
CASP1 P29466 4/20 0.39
KDM4E B2RXH2 4/20 0.39
HPGD P15428 4/20 0.39
TSHR P16473 3/20 0.39
HSD17B10 Q99714 3/20 0.39
GLA P06280 2/20 0.39
GAA P10253 2/20 0.39
CASP7 P55210 2/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
MAPK1 P28482 1/20 0.39
TP53 P04637 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2C9 P11712 1/20 0.39
ALOX15 P16050 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5674294 0.94 BRD4 (0.41) BRD4MAPTALDH1A1MEN1KMT2A
SCHEMBL4589629 0.93 SMN1; SMN2 (0.40) BRD4MAPTALDH1A1MEN1KMT2A
SCHEMBL4589633 0.88 TSHR (0.41) MAPTALDH1A1KMT2ASMN1; SMN2CASP1
SCHEMBL5677672 0.85 MAPT (0.50) MAPTALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL5678203 0.82 MAPT (0.44) BRD4MAPTALDH1A1SMN1; SMN2CASP1
SCHEMBL5675287 0.82 MEN1 (0.54) MAPTALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL5674270 0.82 MAPT (0.47) MAPTALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL194132 0.82 MAPT (0.43) MAPTALDH1A1KMT2ASMN1; SMN2CASP1
SCHEMBL7852811 0.79 IDO1 (0.49) MAPTALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL5435436 0.79 MAPT (0.56) MAPTMEN1KMT2ACASP1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0687251-B1 1,3-DIHYDROINDOL-2-ONE DERIVATIVES SUBSTITUTED IN POSITION 3 BY A NITROGEN GROUP AS VASOPRESSIN AND/OR OCYTOCINE AGONISTS AND/OR ANTAGONISTS SANOFI SYNTHELABO (FR) 2002-02-27 EP disclosed
US-5773612-A VASOPRESSIN OR OXYTOCIN RECEPTORS SANOFI (FR) 1998-06-30 US disclosed
US-5594023-A 1,3-dihydroindol-2-one derivatives substituted in the 3-position by a nitrogen-containing group, their preparation and the pharmaceutical compositions in which they are present SANOFI (FR) 1997-01-14 US disclosed
EP-0687251-A1 1,3-DIHYDROINDOL-2-ONE DERIVATIVES SUBSTITUTED IN POSITION 3 BY A NITROGEN GROUP AS VASOPRESSIN AND/OR OCYTOCINE AGONISTS AND/OR ANTAGONISTS SANOFI (FR) 1995-12-20 EP disclosed
WO-1995018105-A1 1,3-DIHYDROINDOL-2-ONE DERIVATIVES SUBSTITUTED IN POSITION 3 BY A NITROGEN GROUP AS VASOPRESSIN AND/OR OCYTOCINE AGONISTS AND/OR ANTAGONISTS SANOFI (FR) 1995-07-06 WO disclosed